Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - imipramine hydrochloride 25 mg - tablets - imipramine - treatment of various types of depression. in children and adolescents there is not sufficient evidence of safety and efficacy of tofranil in the treatment of all forms of depression. the use of tofranil in children and adolescents ( 0 - 17 years of age) in these indications is therefore not recommended.

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 30 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 20 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 10 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd) .

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - rivastigmine 4.6 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - rivastigmine 9.5 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - clozapine 100 mg - tablets - diazepines, oxazepines, thiazepines and oxepines - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.

Israeli - Kiebrania - Ministry of Health

novartis pharma services ag - pamidronate disodium 90 mg/vial - powder for solution for infusion - bisphosphonates - tumor induced hypercalcaemia, bone metastases and multiple myeloma. for the treatment of paget's disease of bone.